Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report

December 2020 | 40 pages | ID: AA67018A315EN
MarketLine

Abstracts

Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report

Summary

Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Actelion Pharmaceuticals Ltd. (Actelion or 'the company'), a subsidiary of Johnson & Johnson, is a biopharmaceutical company focused on the discovery, development and commercialization of low molecular weight drugs to address high unmet medical needs. The company's business is primarily focused on discovery, development and commercialization of innovative medicines for unmet medical needs. It offers variety of drugs for the treatment of cardiovascular disorders, infectious diseases, cancer, central nervous system disorders, and immunological disorders. The company has its operations in North and South America, Europe and Asia Pacific. The company is headquartered in Allschwil, Switzerland.

Scope

• Detailed information on Actelion Pharmaceuticals Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Actelion Pharmaceuticals Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Actelion Pharmaceuticals Ltd including a breakdown and examination of key business segments
• Intelligence on Actelion Pharmaceuticals Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Actelion Pharmaceuticals Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Actelion Pharmaceuticals Ltd and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Actelion Pharmaceuticals Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Actelion Pharmaceuticals Ltd's business structure, strategy and prospects.

Contents

Company Snapshot
Actelion Pharmaceuticals Ltd: Company Overview
Actelion Pharmaceuticals Ltd: Overview and Key Facts
Actelion Pharmaceuticals Ltd: Overview
Actelion Pharmaceuticals Ltd: Key Facts
Actelion Pharmaceuticals Ltd: Key Employees
Actelion Pharmaceuticals Ltd: Key Employee Biographies
Actelion Pharmaceuticals Ltd: Major Products and Services
Actelion Pharmaceuticals Ltd: Company History
Actelion Pharmaceuticals Ltd: Locations and Subsidiaries
Actelion Pharmaceuticals Ltd: Key Competitors
Actelion Pharmaceuticals Ltd: Company Analysis
Actelion Pharmaceuticals Ltd: Business Description
Actelion Pharmaceuticals Ltd: SWOT Analysis
Actelion Pharmaceuticals Ltd: SWOT Overview
Actelion Pharmaceuticals Ltd: Strengths
Actelion Pharmaceuticals Ltd: Weaknesses
Actelion Pharmaceuticals Ltd: Opportunities
Actelion Pharmaceuticals Ltd: Threats
Actelion Pharmaceuticals Ltd: Corporate Financial Deals Activity
Actelion Pharmaceuticals Ltd: Financial Deals Overview
Actelion Pharmaceuticals Ltd: Targets and Partners
Actelion Pharmaceuticals Ltd: Top Deals 2016 - 2020YTD*
Actelion Pharmaceuticals Ltd: Advisors
Actelion Pharmaceuticals Ltd: Top Legal Advisors
Actelion Pharmaceuticals Ltd: Top Financial Advisors
Actelion Pharmaceuticals Ltd: Partnership
Actelion Pharmaceuticals Ltd: Divestments
Actelion Pharmaceuticals Ltd: Private Equity and Ownership
Actelion Pharmaceuticals Ltd: Recent Developments
Actelion Pharmaceuticals Ltd: News and Events Summary
Actelion Pharmaceuticals Ltd: Business Expansion
Actelion Pharmaceuticals Ltd: Corporate Governance
Actelion Pharmaceuticals Ltd: Financial Performance
Actelion Pharmaceuticals Ltd: Regulatory and Legal Events
Actelion Pharmaceuticals Ltd: Research & Development
Actelion Pharmaceuticals Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Actelion Pharmaceuticals Ltd: Key Facts
Table 2: Actelion Pharmaceuticals Ltd: Key Employees
Table 3: Actelion Pharmaceuticals Ltd: Company History
Table 4: Actelion Pharmaceuticals Ltd: Locations and Subsidiaries
Table 5: Actelion Pharmaceuticals Ltd: Key Competitors
Table 6: Actelion Pharmaceuticals Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Actelion Pharmaceuticals Ltd: Targets and Partners
Table 8: Actelion Pharmaceuticals Ltd: Top Deals 2016 - 2020YTD*
Table 9: Actelion Pharmaceuticals Ltd: Legal Advisor Ranking by Value (US$m)
Table 10: Actelion Pharmaceuticals Ltd: Financial Advisor Ranking by Value (US$m)
Table 11: Actelion Pharmaceuticals Ltd: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 12: Actelion Pharmaceuticals Ltd: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 13: Actelion Pharmaceuticals Ltd: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 14: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 15: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 16: Actelion Pharmaceuticals Ltd: News and Events Summary
Table 17: Actelion Pharmaceuticals Ltd: Business Expansion
Table 18: Actelion Pharmaceuticals Ltd: Corporate Governance
Table 19: Actelion Pharmaceuticals Ltd: Financial Performance
Table 20: Actelion Pharmaceuticals Ltd: Regulatory and Legal Events
Table 21: Actelion Pharmaceuticals Ltd: Research & Development
Table 22: Actelion Pharmaceuticals Ltd: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Actelion Pharmaceuticals Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 2: Actelion Pharmaceuticals Ltd: Partnership Volume and Value Trend (2016 - YTD*2020)
Figure 3: Actelion Pharmaceuticals Ltd: Partnership Trend by Deal Type (2016 - YTD*2020)
Figure 4: Actelion Pharmaceuticals Ltd: Divestments Volume and Value Trend (2016 - YTD*2020)
Figure 5: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Figure 6: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)